1. Home
  2. PPBT vs SAG Comparison

PPBT vs SAG Comparison

Compare PPBT & SAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • SAG
  • Stock Information
  • Founded
  • PPBT 2010
  • SAG 1975
  • Country
  • PPBT Israel
  • SAG Singapore
  • Employees
  • PPBT N/A
  • SAG N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • SAG
  • Sector
  • PPBT Health Care
  • SAG
  • Exchange
  • PPBT Nasdaq
  • SAG NYSE
  • Market Cap
  • PPBT 7.1M
  • SAG 7.1M
  • IPO Year
  • PPBT N/A
  • SAG 2024
  • Fundamental
  • Price
  • PPBT $2.73
  • SAG $1.04
  • Analyst Decision
  • PPBT Strong Buy
  • SAG
  • Analyst Count
  • PPBT 1
  • SAG 0
  • Target Price
  • PPBT $33.00
  • SAG N/A
  • AVG Volume (30 Days)
  • PPBT 16.2K
  • SAG 350.2K
  • Earning Date
  • PPBT 05-20-2025
  • SAG 12-19-2024
  • Dividend Yield
  • PPBT N/A
  • SAG N/A
  • EPS Growth
  • PPBT N/A
  • SAG N/A
  • EPS
  • PPBT N/A
  • SAG 0.21
  • Revenue
  • PPBT N/A
  • SAG $56,387,000.00
  • Revenue This Year
  • PPBT N/A
  • SAG N/A
  • Revenue Next Year
  • PPBT N/A
  • SAG N/A
  • P/E Ratio
  • PPBT N/A
  • SAG $4.90
  • Revenue Growth
  • PPBT N/A
  • SAG N/A
  • 52 Week Low
  • PPBT $2.00
  • SAG $0.47
  • 52 Week High
  • PPBT $20.60
  • SAG $8.27
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 51.95
  • SAG N/A
  • Support Level
  • PPBT $2.67
  • SAG N/A
  • Resistance Level
  • PPBT $2.75
  • SAG N/A
  • Average True Range (ATR)
  • PPBT 0.21
  • SAG 0.00
  • MACD
  • PPBT 0.04
  • SAG 0.00
  • Stochastic Oscillator
  • PPBT 67.19
  • SAG 0.00

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About SAG SAG HOLDINGS LTD

SAG Holdings Ltd engages in the business of distributing automotive and industrial spare parts with operations primarily based in Singapore, and global sales primarily generated from the Middle East and Malaysia. Its business is comprised of On-Highway Business serving the automotive sector and Off-Highway Business primarily servicing the marine, energy, mining, construction, agriculture, and oil and gas sectors. The On-Highway Business Segment supply genuine and aftermarket spare parts to customers through our Autozone retail outlets located in Singapore, as well as Malaysia. The Off-Highway Business Segment supply a wide range of components and spare parts for internal combustion engines with a strong focus on filtration products through Filtec.

Share on Social Networks: